Mylan Inc
MYL:NASDAQ
| Last | Change / % Change | Dividend Yield | Volume |
| 22.80 | 0.0700 0.31% | 0.00% | 2,259,236 |
Market data is delayed by at least 20 minutes.
Exclusive Features
When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes.
For full analysis details, Log In with Scottrade or you can:
Latest News Headlines for Mylan Inc
Mylan Laboratories (MYL) Showing Bullish Technicals With Support At $22.25
Mylan Inc (NASDAQ: MYL) closed Tuesday's trading session at $22.58. In the past year, the stock has hit a 52-week low of $16.55 and 52-week high of $23.63. Mylan Laboratories stock has been showing support around $22.25 and resistance in the $22.89 range. Technical indicators for the stock are Bullish and S&P; gives MYL a very positive 5 STARS (out of 5) strong buy rating. For a hedged play on this stock, look at the Jul '11 $23.00 covered call for a net debit in the $20.99 area. That is also the break-even stock price for this trade. This covered call has a duration of 185 days, provides 7.04% downside protection and an assigned return rate of 9.58% for an annualized return rate of 18.89% (for comparison purposes only). A lower-cost hedged play for this stock would use a longer term call option in place of the covered call stock purchase. To use this strategy look at going long the MYL Jan '12 $17.50 call and selling the Jul '11 $23.00 call for a total debit of $4.51. The trade has a lifespan of 185 days and would provide 2.52% downside protection and an assigned return rate of 21.95% for an annualized return rate of 43% (for comparison purposes only). Mylan Laboratories does not pay dividends at this time.
Watch for Mylan to Potentially Pullback after Gaining 0.45% Yesterday (MYL)
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $22.08 to a high of $22.55. Yesterday, the shares gained 0.45%, which took the trading range above the 3-day high of $22.54 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend's Option Scanner Detects Unusual Activity in Mylan (MYL)
View more recent headlinesShares of Mylan (NASDAQ:MYL) are trading 0.7% higher today, recently trading at $22.47. The stock has been drifting higher over the past ten trading days and is currently trading in a technical uptrend.
Company Background
Mylan Inc. (Mylan) is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). It operates through two business segments: Generics and Specialty. The Generics Segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule or transdermal patch form, as well as API. The Specialty Segment engages mainly in the manufacture and sale of branded specialty nebulized and injectable products. As of December 31, 2009, Mylan marketed more than 900 different products covering an array of therapeutic categories to consumers in more than 140 countries and territories across the globe. During the year ended December 31, 2009, the Company acquired approximately 25% of the remaining interest in Matrix Laboratories Limited, bringing both its total ownership and control to over 96%.
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 22.63 | Previous Close 22.73 |
Day High 22.80 | Day Low 22.60 |
52wk High/Date 23.63 / 4/5/2010 | 52wk Low/Date 16.55 / 7/1/2010 |
Beta 0.72 | Market Capitalization 9.92B |
Shares Outstanding 435.22M | Volatility Avg 24.47 |
Avg Vol(10 day) 5.56M | P/E Ratio 32.6x |
EPS (TTM) 0.70 | Annualized Rate -- / -- |
Yield 0.00% | Dividend Announcement -- |
Ex-Date -- | Date of Record -- |
Payable 0.00 - -- | Payable Date -- |
Last Trade as of 1/14/2011 4:00 PM ET | |
Exclusive Content
When you open an account with Scottrade, you will get premium content on the News & Content page, including:
- Standard & Poor's News and Commentary
- Dow Jones News
- Briefing News and Commentary
- Market Edge On the Edge Commentary
For full analysis details, Log In with Scottrade or you can:
MYL Mylan Inc vs. Peers
| Peers | |
MYL Mylan Inc | 7.90% |
| JNJ Johnson & Johnson | 1.13% |
| MRK Merck & Co., Inc. | -5.02% |
| ABT Abbott Laboratories | -2.13% |
| PFE Pfizer Inc. | 4.74% |
MYL Mylan Inc | 0.00% |
| JNJ Johnson & Johnson | 3.45% |
| MRK Merck & Co., Inc. | 4.44% |
| ABT Abbott Laboratories | 3.75% |
| PFE Pfizer Inc. | 4.36% |
MYL Mylan Inc | 0.31% |
| JNJ Johnson & Johnson | -0.57% |
| MRK Merck & Co., Inc. | -1.33% |
| ABT Abbott Laboratories | -1.01% |
| PFE Pfizer Inc. | 0.66% |